French Auto Components Stock News

SCOR (ENXTPA:SCR) delivered a remarkable 173.2% earnings growth year-over-year, far outpacing its five-year average of 3.5% per year. Net profit margins rose to 3.3% from 1.2% last year, and with shares trading at a Price-to-Earnings Ratio of 8.7x, which is below the European Insurance industry average, investors may see opportunity in this combination of improving profitability and relative value. While the company trades below estimated fair value and shows steady revenue growth forecasts,...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Imerys (ENXTPA:NK) remains in the red, with losses worsening at an annual rate of 43.6% over the past five years. Looking ahead, earnings are forecast to climb 17.67% per year, and the company is projected to swing to profitability in the next three years. This growth is expected to outpace average market growth. However, revenue is expected to rise just 4.1% annually, trailing behind the French market’s 5.6% benchmark. As a result, investors are left to weigh turnaround potential against...

Viridien Société anonyme (ENXTPA:VIRI) is currently unprofitable but has managed to shrink its losses at an impressive rate of 74% per year over the last five years. Expectations are for the company to hit profitability within the next three years, with earnings projected to rise at 7.98% annually, while revenue is set to grow at 4.5% per year, lagging behind the French market average of 5.6%. With the share price at €106, which is above the estimated fair value of €99.62, investors are...

Vivendi (ENXTPA:VIV) released its latest unaudited financial results, highlighting a small dip in third quarter revenue, but a 5% rise for the first nine months, thanks largely to Gameloft’s improved numbers. See our latest analysis for Vivendi. Vivendi’s solid revenue growth from Gameloft has helped brighten its broader narrative, and investors seem to have noticed. Despite some recent softness, with a 4.57% drop in the past week, the stock’s total shareholder return of 43.61% over the past...

VusionGroup (ENXTPA:VU) just landed a high-profile partnership with UK grocer Morrisons, who will roll out electronic shelf labels across all its stores. This comes as VusionGroup reconfirms its upbeat earnings guidance and expects record Q4 revenue. See our latest analysis for VusionGroup. VusionGroup’s win at Morrisons and strengthened guidance have caught investor attention, with the company’s share price up 25.3% year-to-date and a one-year total shareholder return of 58.3%. Momentum has...

Rexel (ENXTPA:RXL) has caught investor attention recently with its shares seeing steady movement. Over the past month, Rexel’s stock has delivered a solid 8% gain, prompting some market watchers to take a closer look. See our latest analysis for Rexel. Zooming out, Rexel’s 23% share price return so far this year builds on impressive momentum, with a 90-day gain of over 15% and a three-year total shareholder return nearing 98%. Recent share movement suggests confidence is rising and hints at...

Today we're going to take a look at the well-established Publicis Groupe S.A. ( EPA:PUB ). The company's stock saw a...

Sanofi's ( EPA:SAN ) recent earnings report didn't offer any surprises, with the shares unchanged over the last week...

We.Connect SA's ( EPA:ALWEC ) robust recent earnings didn't do much to move the stock. We think this is due to...

Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. Active...

Key Insights VusionGroup's significant retail investors ownership suggests that the key decisions are influenced by...

Bastide Le Confort Médical SA's ( EPA:BLC ) stock was strong despite it releasing a soft earnings report last week. We...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Amongst other...

Toosla Société Anonyme's ( EPA:ALTOO ) price-to-sales (or "P/S") ratio of 0.2x might make it look like a buy right now...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Key Insights ABIONYX Pharma's significant retail investors ownership suggests that the key decisions are influenced by...

When close to half the companies in France have price-to-earnings ratios (or "P/E's") above 17x, you may consider...

For many investors, the main point of stock picking is to generate higher returns than the overall market. But in any...

Mersen recently reported Q3 results that missed market expectations, citing ongoing weakness in its solar power segment and reducing its full-year organic sales growth, profit margin, and capital expenditure guidance due to a lack of recovery in this area. An important takeaway is that management expressed limited visibility on a turnaround in the solar segment, prompting analysts to anticipate downward revisions to consensus estimates for the company. We'll explore how weak activity and...

Mersen (ENXTPA:MRN) caught investor attention after its shares took a steep dive, following the release of Q3 results that fell short of expectations. This was driven largely by sluggish performance in its solar power segment. See our latest analysis for Mersen. After gaining impressive ground for much of 2024, Mersen's share price has now swung sharply as recent weak solar segment results rattled the market. The stock dropped 18.3% in a single day but still holds a 12.4% year-to-date price...

Thinking about what’s next for Amundi’s stock? You are not alone. Whether you have held on through the years or are weighing a new position, it is hard to ignore a company that has delivered nearly 71% growth over the past three years. Even if the pace has slowed, with a 3.0% rise so far this year and a modest 1.0% bump just this past week, there is a sense that something is stirring beneath the surface. Some of that recent uplift comes on the back of Amundi’s push into new markets and the...

Sanofi (ENXTPA:SAN) delivered net profit margins of 14%, up from 9.3% a year ago, and last year’s earnings grew 73.6% after five years of average annual declines of 14.5%. With earnings now forecast to climb 12.48% per year and profit and revenue expected to outpace the broader French market, these headline numbers make a strong case for a shift in investor sentiment. Improved profitability, a six-reward indicator profile, and a substantially lower Price-To-Earnings Ratio compared to peers...